131 related articles for article (PubMed ID: 8103962)
1. Sulphasalazine in rheumatic diseases.
Dougados M
Agents Actions Suppl; 1993; 44():197-201. PubMed ID: 8103962
[TBL] [Abstract][Full Text] [Related]
2. [Sulfasalazine in rheumatology].
Nurchis P; Garau P; Pala MR; Uras L; Saviano M; Mathieu A
Ann Ital Med Int; 1990; 5(3 Pt 1):186-91. PubMed ID: 1981136
[TBL] [Abstract][Full Text] [Related]
3. Sulphasalazine: mechanism of action in rheumatoid arthritis.
Smedegård G; Björk J
Br J Rheumatol; 1995 Nov; 34 Suppl 2():7-15. PubMed ID: 8535652
[TBL] [Abstract][Full Text] [Related]
4. The history of the use of sulphasalazine in rheumatology.
Amos RS
Br J Rheumatol; 1995 Nov; 34 Suppl 2():2-6. PubMed ID: 8535643
[TBL] [Abstract][Full Text] [Related]
5. [Sulphasalazine: a promising drug in rheumatology].
Nasonov EL
Klin Med (Mosk); 1997; 75(6):39-44. PubMed ID: 9273399
[No Abstract] [Full Text] [Related]
6. The antirheumatic agents sulphasalazine and methotrexate share an anti-inflammatory mechanism.
Cronstein BN
Br J Rheumatol; 1995 Nov; 34 Suppl 2():30-2. PubMed ID: 8535646
[TBL] [Abstract][Full Text] [Related]
7. Sulphasalazine, sulphapyridine or 5-aminosalicylic acid--which is the active moiety in rheumatoid arthritis?
Bird HA
Br J Rheumatol; 1995 Nov; 34 Suppl 2():16-9. PubMed ID: 8535642
[TBL] [Abstract][Full Text] [Related]
8. [Significance of intestinal inflammation in the pathogenesis of spondylarthropathies].
Mielants H; Veys EM
Verh K Acad Geneeskd Belg; 1996; 58(2):93-116. PubMed ID: 8768479
[TBL] [Abstract][Full Text] [Related]
9. Differential efficacy of tumor necrosis factor inhibition in the management of inflammatory eye disease and associated rheumatic disease.
Smith JR; Levinson RD; Holland GN; Jabs DA; Robinson MR; Whitcup SM; Rosenbaum JT
Arthritis Rheum; 2001 Jun; 45(3):252-7. PubMed ID: 11409666
[TBL] [Abstract][Full Text] [Related]
10. Sulphasalazine in arthritis--an old drug rediscovered.
Taggart AJ
Clin Rheumatol; 1987 Sep; 6(3):378-83. PubMed ID: 2894913
[TBL] [Abstract][Full Text] [Related]
11. [Sulfasalazine as an antirheumatic agent; a review of the literature].
Zanen P
Ned Tijdschr Geneeskd; 1988 Jan; 132(5):196-9. PubMed ID: 2893300
[No Abstract] [Full Text] [Related]
12. The use of sulphasalazine as a disease modifying antirheumatic drug.
Porter DR; Capell HA
Baillieres Clin Rheumatol; 1990 Dec; 4(3):535-51. PubMed ID: 1982707
[TBL] [Abstract][Full Text] [Related]
13. Possible mechanisms of action of antimalarials in rheumatic disease.
Cutler DJ
Agents Actions Suppl; 1993; 44():139-43. PubMed ID: 8372722
[TBL] [Abstract][Full Text] [Related]
14. Clinical efficacy of sulphasalazine--a review.
Capell HA
Br J Rheumatol; 1995 Nov; 34 Suppl 2():35-9. PubMed ID: 8535647
[TBL] [Abstract][Full Text] [Related]
15. Rheumatoid arthritis: a risk factor for sulphasalazine toxicity? A meta-analysis.
Wijnands MJ; Van 'T Hof MA; Van De Putte LB; Van Riel PL
Br J Rheumatol; 1993 Apr; 32(4):313-8. PubMed ID: 8096419
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics in the rheumatic diseases.
Cronstein BN
Bull NYU Hosp Jt Dis; 2006; 64(1-2):16-9. PubMed ID: 17121484
[TBL] [Abstract][Full Text] [Related]
17. Etanercept: new preparation. Useful after methotrexate failure in inflammatory rheumatism.
Prescrire Int; 2003 Aug; 12(66):127-32. PubMed ID: 12906020
[TBL] [Abstract][Full Text] [Related]
18. Combination of sulphasalazine and methotrexate in the management of rheumatoid arthritis--view based on personal clinical experience.
Shiroky JB
Br J Rheumatol; 1995 Nov; 34 Suppl 2():109-12. PubMed ID: 8535641
[TBL] [Abstract][Full Text] [Related]
19. Leflunomide for rheumatoid arthritis.
Drug Ther Bull; 2000 Jul; 38(7):52-4. PubMed ID: 11027115
[TBL] [Abstract][Full Text] [Related]
20. An update on methotrexate.
Braun J; Rau R
Curr Opin Rheumatol; 2009 May; 21(3):216-23. PubMed ID: 19373092
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
